FetusFluorodeoxyglucose F18Positron-Emission Tomography
Dr. Mark S. Kaminski, MD
NPI1053499954
- Medicare services, 2023
- 15
- Part D claims, 2024
- 12
- Publications
- 49
- Clinical trials
- 1
- Hospital affiliations
- 1
- Practice address
- 28050 Grand River Ave, Farmington Hills, MI 48336
- Practice phone
- Call (947) 521-8000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Beaumont Hospital - Farmington Hills
Farmington Hills, Michigan
Find Dr. Kaminski's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mark S. Kaminski is a medical oncologist in Farmington Hills, Michigan
Dr. Kaminski practices at Beaumont Hospital - Farmington Hills in Farmington Hills, Michigan.
Dr. Kaminski's NPI, 1053499954, was assigned on November 1, 2006. Dr. Kaminski graduated from Stanford University School of Medicine in 1978. Dr. Kaminski holds Michigan license 4301049516.
NPI and contact details
- NPI
- 1053499954NPI Registry (opens in a new tab)
- NPI enumeration date
- November 1, 2006
- NPI status
- Active
- Practice phone
- (947) 521-8000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 74
- Medical school graduation
- 1978
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Mark S. Kaminski practices at Beaumont Hospital - Farmington Hills in Farmington Hills, Michigan
Dr. Kaminski's primary practice is Beaumont Hospital - Farmington Hills, at 28050 Grand River Ave, Farmington Hills, MI 48336 in Oakland County. The practice phone is (947) 521-8000.
- Beaumont Hospital - Farmington Hills28050 Grand River Ave, Farmington Hills, MI 48336 · Oakland CountyPhone(947) 521-8000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Mark S. Kaminski is affiliated with 2 sites of care and 1 medical group
Dr. Kaminski's primary practice is Beaumont Hospital - Farmington Hills in Farmington Hills, Michigan. Dr. Kaminski is also affiliated with University Hospital. The medical group on file is University of Michigan Health.
Beaumont Hospital - Farmington HillsPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mark S. Kaminski's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaminski practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Beaumont Hospital - Farmington Hills | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kaminski practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mark S. Kaminski is one of 171 medical oncologists in Michigan
Medical oncology is Dr. Kaminski's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kaminski is licensed in Michigan.
Specialties and state licenses
- Medical oncology, MichiganPrimary
Medical oncologists near Dr. Kaminski
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
171medical oncologists in Michigan
5medical oncologists in Farmington Hills
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mark S. Kaminski billed Medicare for 15 services in 2023
CMS data shows 15 Medicare services from Dr. Kaminski across 1 procedure code in 2023, all of them office visits. Medicare paid $649 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 202315
Paid by Medicare$649
Procedure codes1
Dr. Kaminski's Medicare services by type, 2022 to 2023
- 2022
- 2023
- Office and hospital visits
- 2022: 3312023: 1595%
Dr. Kaminski compared with the Michigan median for medical oncologists, 2023
- Dr. Kaminski
- Michigan median
- Medicare services
- 15vs 36496% below
- Part D claims
- 51vs 33485% below
Medians across 165 medical oncologists in Michigan with Dmand AI profiles that report each measure.
Dr. Kaminski's most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kaminski?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kaminski and other medical oncologists in Michigan.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mark S. Kaminski's patients have a median age of 67
Across all payers, Dmand AI patient panel data puts Dr. Kaminski's median patient age at 67, with 43% women.
Dr. Kaminski's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women43%
- Men57%
Source: Dmand AI Patient Panel Data
Dr. Mark S. Kaminski wrote 12 Medicare Part D claims in 2024
In 2024, Dr. Kaminski wrote 12 Medicare Part D claims. They cover 4 drugs, with $462,348 in total drug cost. In 2022, CMS named 124 claims across 6 drugs.
Part D claims, 202412
Drugs named by CMS4
Total drug cost$462,348
Dr. Kaminski's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 1242023: 5159%
Drugs named by CMS: 4 in 2023, 6 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find medical oncologists like Dr. Kaminski by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mark S. Kaminski has 49 publications on record
Dmand AI links 49 papers to Dr. Kaminski, published from 2011 to 2022. 2014 was the busiest year, with 8. The most frequent topics are Lymphoma, Follicular, Antineoplastic Combined Chemotherapy Protocols and Lymphoma, Large B-Cell, Diffuse. Dr. Kaminski has published most often in J Natl Compr Canc Netw. Dr. Kaminski's most frequent co-authors are Tycel Jovelle Phillips, MD, Leo I. Gordon, MD and Rachel A. Rabinovitch, MD.
Papers49
Years published2011 to 2022
Dr. Kaminski's papers by year, 2013 to 2022
Topics Dr. Kaminski writes about most
- Lymphoma, Follicular
- Antineoplastic Combined Chemotherapy Protocols
- Lymphoma, Large B-Cell, Diffuse
- Rituximab
- Antibodies, Monoclonal
- Antineoplastic Agents
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell, Peripheral
Dr. Kaminski's most frequent co-authors
- Tycel Jovelle Phillips, MD11 shared papers
- Leo I. Gordon, MD9 shared papers
- Rachel A. Rabinovitch, MD8 shared papers
Recent publications by Dr. Kaminski
J Oncol Pharm Pract
Antineoplastic Combined Chemotherapy ProtocolsCOVID-19Cyclophosphamide
See who Dr. Kaminski researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kaminski works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mark S. Kaminski has worked on 1 clinical trial
Dmand AI links Dr. Kaminski to 1 clinical trial. Conditions studied include Lymphoma, Non-Hodgkin and Lymphoma.
Conditions in Dr. Kaminski's trials
- Lymphoma, Non-Hodgkin
- Lymphoma
Investigators on the most trials with Dr. Kaminski
Recent clinical trials with Dr. Kaminski
Lymphoma, Non-HodgkinLymphomaBortezomib, tositumomab
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mark S. Kaminski received $6,331 in industry payments from 2016 to 2019
CMS Open Payments shows 22 general payments to Dr. Kaminski from 8 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 87% of the total. Gilead Sciences, Inc. paid the most, $3,365.
General payments to Dr. Kaminski by program year, 2016 to 2019
General payments to Dr. Kaminski by kind, 2016 to 2019
$6.3Kin total
- Consulting fees$5,50087%
- Food and beverage$5308%
- Travel and lodging$3015%
Companies that paid Dr. Kaminski the most, 2016 to 2019
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mark S. Kaminski graduated from Stanford University School of Medicine
Dr. Kaminski graduated from Stanford University School of Medicine in 1978.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Mark S. Kaminski's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mark S. Kaminski
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mark S. Kaminski's NPI number?
Dr. Mark S. Kaminski's NPI number is 1053499954. It was assigned on November 1, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mark S. Kaminski?
Dr. Mark S. Kaminski is a medical oncologist in Farmington Hills, Michigan. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Mark S. Kaminski practice?
Dr. Kaminski practices at 28050 Grand River Ave, Farmington Hills, MI 48336. Dr. Kaminski's primary practice is Beaumont Hospital - Farmington Hills in Farmington Hills, Michigan.
What is Dr. Mark S. Kaminski's office phone number?
The practice phone on file for Dr. Kaminski is (947) 521-8000.
What is Dr. Mark S. Kaminski's medical license number?
Dr. Kaminski holds Michigan license 4301049516.
Which hospitals is Dr. Mark S. Kaminski affiliated with?
Dr. Kaminski is affiliated with University Hospital.
What medical group is Dr. Mark S. Kaminski part of?
Dr. Kaminski is linked to University of Michigan Health.
Does Dr. Mark S. Kaminski accept Medicare?
Yes. CMS data shows Dr. Kaminski billed Medicare for 15 services in 2023.
What services does Dr. Mark S. Kaminski bill to Medicare?
In 2023, Dr. Kaminski's most billed Medicare services were office visit, established patient (99214).
Where did Dr. Mark S. Kaminski go to medical school?
Dr. Kaminski graduated from Stanford University School of Medicine in 1978.
Show 5 more questionsShow fewer questions
What drugs does Dr. Mark S. Kaminski prescribe most?
In 2023 Medicare Part D data, Dr. Kaminski's most prescribed drugs by claims were Brukinsa, Imbruvica and Acyclovir.
Has Dr. Mark S. Kaminski received payments from drug or device companies?
CMS Open Payments shows $6,331 in general payments to Dr. Kaminski from 8 companies from 2016 to 2019. The largest total came from Gilead Sciences, Inc.
How long has Dr. Mark S. Kaminski been practicing?
Dr. Kaminski graduated from medical school in 1978, 48 years ago.
Does Dr. Mark S. Kaminski do research?
Dmand AI links 49 publications to Dr. Kaminski, published from 2011 to 2022. Dr. Kaminski has worked on 1 clinical trial.
Who does Dr. Mark S. Kaminski publish with?
Dr. Kaminski's most frequent co-authors are Tycel Jovelle Phillips, MD (11 shared papers), Leo I. Gordon, MD (9 shared papers) and Rachel A. Rabinovitch, MD (8 shared papers).
Selling to medical oncology practices?
See medical oncologists in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card